Su et al. [37] reported that MARCH1 suppressed bladder cancer growth, while Xu et al. [38] demonstrated that MARCH1 expression was decreased significantly in colon adenocarcinoma (COAD), lung adenocarcinoma, lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PAAD), and rectum adenocarcinoma (READ). Here, MARCHF1 is linked to urinary bladder carcinoma.